Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
Sagility Ltd, Inox Green Energy Services Ltd, Archean Chemical Industries Ltd and Mankind Pharma Ltd are among the other losers in the BSE's 'A' group today, 31 July 2026.
Thangamayil Jewellery Ltd lost 10.00% to Rs 5233.8 at 14:46 IST.The stock was the biggest loser in the BSE's 'A' group.On the BSE, 60494 shares were traded on the counter so far as against the average daily volumes of 18570 shares in the past one month.
Sagility Ltd crashed 5.59% to Rs 43.42. The stock was the second biggest loser in 'A' group.On the BSE, 27.19 lakh shares were traded on the counter so far as against the average daily volumes of 23.67 lakh shares in the past one month.
Inox Green Energy Services Ltd tumbled 5.00% to Rs 166.25. The stock was the third biggest loser in 'A' group.On the BSE, 77127 shares were traded on the counter so far as against the average daily volumes of 76682 shares in the past one month.
Archean Chemical Industries Ltd corrected 4.93% to Rs 534. The stock was the fourth biggest loser in 'A' group.On the BSE, 24322 shares were traded on the counter so far as against the average daily volumes of 34110 shares in the past one month.
Mankind Pharma Ltd shed 4.56% to Rs 2459.45. The stock was the fifth biggest loser in 'A' group.On the BSE, 1.07 lakh shares were traded on the counter so far as against the average daily volumes of 26012 shares in the past one month.
The exchange said the introduction of the contracts is based on the stock selection criteria prescribed by the Securities and Exchange Board of India (SEBI) and the regulator's approval.
NSE said the market lot and strike price scheme for the three securities will be announced through a separate circular on 25 August 2026. Details of the applicable quantity freeze will also be made available in the contract file before trading commences.
The company reported profit before exceptional items and tax of Rs 302.57 crore in Q1 FY27, compared with Rs 210.39 crore a year ago. The firm reported exceptional items of Rs 15.09 crore during the quarter.
In Q1 FY27, adjusted EBITDA stood at Rs 471.6 crore, up 27.9%, compared with Rs 368.7 crore posted in the same quarter last year. Adjusted EBITDA margin stood at 24% in Q1 FY27 as against 24% in Q1 FY26.
In dollar terms, the company reported revenue of $207.8 million, while adjusted PAT stood at $28.6 million in Q1 FY27. In constant currency terms, revenue grew 15.2% YoY, while organic growth came in at 27.3% YoY (14.9% in constant currency).
As of 30 June 2026, the company had 47,307 employees and operated 29 delivery centers across five countries. Voluntary attrition stood at 28.6% in Q1 FY27, compared with 27.6% in Q1 FY26.
Ramesh Gopalan, managing director and group CEO, said, “Healthcare organizations are increasingly looking for partners that can combine healthcare expertise with technology, AI, and operational accountability to deliver measurable outcomes. We are seeing growing demand for outcome-oriented managed services engagements, and the early momentum behind Sagility Synchrony reinforces our belief that the future of healthcare operations lies in more integrated, intelligent operating models. Our acquisition of CareSeed further strengthens our capabilities in healthcare quality and expands our reach in the Medicare Advantage and mid-market segments.”
Srinivas Mattapalli, Group Chief Financial Officer, added, 'We have started the year on a strong note, supported by healthy business momentum, resilient profitability and robust cash generation. Our performance reflects the strength of Sagility’s healthcare-focused model, the depth of our client relationships and our strong execution across markets. With a strong balance sheet, healthy cash flows and clear strategic priorities, we remain well-placed to invest in growth, strengthen our capabilities and drive sustainable long-term value for our stakeholders.”
Sagility is a global provider of technology-enabled business solutions and services to clients in the U.S. healthcare industry.
The acquisition, approved by the board of directors at its meeting held on June 11, 2026, is a cash transaction. The deal is expected to be completed on the same date.
CareSeed, headquartered in Kansas City, Missouri, reported a turnover of USD 5.1 million in CY2025. The company operates in the US healthcare analytics and technology space, offering NCQA-certified HEDIS reporting, medical record review, chart abstraction, and regulatory analytics solutions for health plans.
Sagility said the acquisition aligns with its strategy to strengthen healthcare quality measurement and risk adjustment capabilities and expand into STAR performance management and care gap closure services.
CareSeed currently serves around 30 mid-sized US health plans, primarily in the Medicare Advantage segment. Its cloud-based platforms, Forecast and Harvest, support HEDIS reporting, audit readiness, and regulatory compliance.
The company said the acquisition will enhance its healthcare quality and Stars capabilities and enable expansion into integrated quality orchestration across payer ecosystems.
The deal is expected to strengthen Sagility’s position in the US healthcare payer market and create cross-selling opportunities across technology and clinical services.
The company’s consolidated net profit jumped 41.2% to Rs 257.73 crore on 29.1% rise in revenue from operations to Rs 2,024.26 crore in Q4 FY26 over Q4 FY25.
For the full year,net profit rose 71.53% to Rs 924.77 crore in the year ended March 2026 as against Rs 539.12 crore during the previous year ended March 2025. Sales rose 29.14% to Rs 7192.85 crore in the year ended March 2026 as against Rs 5569.92 crore during the previous year ended March 2025.